edit-301
Editas Medicine
['ruby']
we are looking forward to tomorrow at #eha2023 as we present clinical data from the ruby trial of edit-301 for the treatment of severe sickle cell disease. learn more: #sicklecelldisease #geneediting #biotechnology 
At Editas Medicine, we are pioneering the possible, harnessing the potential of CRISPR gene editing to develop medicines for people living with serious diseases